Global Cell Expansion Market

1 INTRODUCTION OF GLOBAL CELL EXPANSION MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL CELL EXPANSIONMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL CELL EXPANSION MARKET, BY APPLICATION:
5.1 Regenerative Medicine and Stem Cell Research
5.2 Cancer and Cell-Based Research
5.3 Others

6 GLOBAL CELL EXPANSION MARKET, BY END USER:
6.1 Research Institutes
6.2 Biopharmaceutical and Biotechnology Companies
6.3 Cell Banks
6.4 Others

7 GLOBAL CELL EXPANSION MARKET, BY PRODUCT:
7.1 Consumables
7.1.1 Reagent, Media, Sera
7.2 Disposables
7.2.1 Tissue Culture Flasks
7.2.2 Bioreactor Accessories
7.2.3 Other Disposables
7.3 Instruments
7.3.1 Flow Cytometers
7.3.2 Centrifuges
7.3.3 Cell Counters
7.3.4 Other Supporting Equipment
7.4 Bioreactors
7.4.1 Micro carrier Bioreactors

8 GLOBAL CELL EXPANSIONMARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

9 GLOBAL CELL EXPANSIONMARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 Thermo Fisher Scientific, Inc.
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 GE Healthcare (A Wholly Owned Subsidiary of General Electric Company)
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Lonza Group Ltd.
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Becton, Dickinson and Company
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Corning, Inc.
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Merck KGAA
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 MiltenyiBiotec
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Stemcell Technologies
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Development

10.10 Terumo BCT, Inc. (A Subsidiary of Terumo Corporation)
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Development

11 Appendix
11.1 Related Reports